Pharmacological management of apathy in dementia

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS drugs, 2022 - Springer
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …
被引用次数：23 相关文章

Pharmacological Management of Apathy in Dementia

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS …, 2022 - pubmed.ncbi.nlm.nih.gov
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …

Pharmacological management of apathy in dementia.

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS Drugs, 2022 - psycnet.apa.org
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …

Pharmacological Management of Apathy in Dementia

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS …, 2022 - search.proquest.com
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …

Pharmacological Management of Apathy in Dementia.

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS Drugs, 2022 - europepmc.org
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …

Pharmacological Management of Apathy in Dementia.

L Azhar, RW Kusumo, G Marotta, KL Lanctôt… - CNS …, 2022 - search.ebscohost.com
Apathy is a highly prevalent symptom of dementia. Despite its association with faster
cognitive and functional decline, decreased quality of life and increased mortality, no …